Evidence map›Paper›PMID 34242767›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2021

Drug exposure may have a substantial influence on COVID-19 prognosis among residents of long-term care facilities: an exploratory analysis.

Laura Soldevila, Lluís Valerio-Sallent, Sílvia Roure, Olga Pérez-Quílez, Miquel Àngel Mas, Ramón Miralles, Israel López-Muñoz, Oriol Estrada, Xavier Vallès

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Laura SoldevilaInfectious Diseases Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; International Health Program, Regió Sanitària Metropolitana Nord, Institut Català de la Salut, Badalona, Spain.
Lluís Valerio-SallentInternational Health Program, Regió Sanitària Metropolitana Nord, Institut Català de la Salut, Badalona, Spain.
Sílvia RoureInfectious Diseases Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; International Health Program, Regió Sanitària Metropolitana Nord, Institut Català de la Salut, Badalona, Spain.
Olga Pérez-QuílezInternational Health Program, Regió Sanitària Metropolitana Nord, Institut Català de la Salut, Badalona, Spain.
Miquel Àngel MasDirecció Clínica Territorial Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain; Geriatrics Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Ramón MirallesDirecció Clínica Territorial Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain; Geriatrics Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Israel López-MuñozInternational Health Program, Regió Sanitària Metropolitana Nord, Institut Català de la Salut, Badalona, Spain.
Oriol EstradaGerència Territorial, Regió Sanitària Metropolitana Nord, Institut Català de la Salut, Badalona, Spain.
Xavier VallèsInternational Health Program, Regió Sanitària Metropolitana Nord, Institut Català de la Salut, Badalona, Spain; Institut per la Recerca en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain. Electronic address: xvallesc.mn.ics@gencat.cat.
Institut Català de la Salut · ESHospital Universitari Germans Trias i Pujol · ESInstitut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo explore the association between drug exposure and SARS-CoV-2 prognosis among elderly people living in long-term care facilities (LTC)

designWe carried out a cross-sectional study among old people living in LTC that had a proven SARS-CoV-2 infection, including socio-demographic data, comorbidities and drug intake at the moment of the diagnosis. The study was focused on ACE2 inhibitors, ARA-II blockers, inhaled bronchodilators, oral corticoids, platelet antiaggregants, oral anti-coagulants, statins and Vitamin D.

results1 306 individuals were included, with a mean age of 86.7 years, and 72.3% were females. The case fatality rate was 24.4%. Among the studied exposures platelet antiaggregants were the most prevalent (24.7%). After adjusting for propensity score, the intake of inhaled corticoids (OR 0.73; p=0.03) and statins (OR 0.65; p=0.03) were found to be protective factors of death, whereas ACE2 inhibitor showed an almost significant association (OR 0.73, p=0.07).

conclusionsConsidering the high prevalence of drug intake among elderly people, drug exposure may be an important Covid-19 disease modifier in LTC residents and should be considered when exploring prognostic risk factors associated to Covid-19.

Indexed as

COVID-19Pharmaceutical PreparationsAgedAged, 80 and overCross-Sectional StudiesFemaleHumansLong-Term CarePrognosisSARS-CoV-2Pharmaceutical PreparationsACE2 inhibitorsCovid-19drug exposureinhaled corticoidslong-term care facilitiesSARS-CoV-2statins

Identifiers

PMID34242767
PMCPMC8260494
OpenAlexW3181490086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.